Scholar Rock Holding Corporation (SRRK): Price and Financial Metrics

Scholar Rock Holding Corporation (SRRK): $5.05

-0.13 (-2.51%)

POWR Rating

Component Grades













Add SRRK to Watchlist
Sign Up

Industry: Biotech



in industry


  • Growth is the dimension where SRRK ranks best; there it ranks ahead of 55.1% of US stocks.
  • SRRK's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • SRRK's current lowest rank is in the Momentum metric (where it is better than 14.48% of US stocks).

SRRK Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for SRRK is 0.11 -- better than merely 11.91% of US stocks.
  • Of note is the ratio of Scholar Rock Holding Corp's sales and general administrative expense to its total operating expenses; merely 12.05% of US stocks have a lower such ratio.
  • With a price/sales ratio of 25.72, Scholar Rock Holding Corp has a higher such ratio than 94.03% of stocks in our set.
  • Stocks that are quantitatively similar to SRRK, based on their financial statements, market capitalization, and price volatility, are CCCC, NTLA, ORMP, MTEM, and FDMT.
  • SRRK's SEC filings can be seen here. And to visit Scholar Rock Holding Corp's official web site, go to

SRRK Valuation Summary

  • SRRK's price/earnings ratio is -12.6; this is 134.52% lower than that of the median Healthcare stock.
  • Over the past 40 months, SRRK's price/sales ratio has gone NA NA.
  • SRRK's EV/EBIT ratio has moved up 1.1 over the prior 40 months.

Below are key valuation metrics over time for SRRK.

Stock Date P/S P/B P/E EV/EBIT
SRRK 2021-08-31 86.3 6.3 -12.6 -11.1
SRRK 2021-08-30 84.0 6.1 -12.2 -10.8
SRRK 2021-08-27 87.7 6.4 -12.7 -11.3
SRRK 2021-08-26 85.5 6.2 -12.4 -11.0
SRRK 2021-08-25 86.4 6.3 -12.6 -11.1
SRRK 2021-08-24 87.0 6.3 -12.6 -11.2

SRRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SRRK has a Quality Grade of D, ranking ahead of 18.4% of graded US stocks.
  • SRRK's asset turnover comes in at 0.051 -- ranking 322nd of 681 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows SRRK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.051 1 -0.678
2021-03-31 0.056 1 -0.719
2020-12-31 0.070 1 -0.841
2020-09-30 0.113 1 -0.949
2020-06-30 0.119 1 -0.788
2020-03-31 0.118 1 -0.618

SRRK Price Target

For more insight on analysts targets of SRRK, see our SRRK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $64.67 Average Broker Recommendation 1.3 (Strong Buy)

SRRK Stock Price Chart Interactive Chart >

Price chart for SRRK

SRRK Price/Volume Stats

Current price $5.05 52-week high $44.95
Prev. close $5.18 52-week low $4.84
Day low $4.84 Volume 489,600
Day high $5.16 Avg. volume 383,311
50-day MA $9.64 Dividend yield N/A
200-day MA $22.62 Market Cap 178.28M

Scholar Rock Holding Corporation (SRRK) Company Bio

Scholar Rock Holding Corporation discovers and develops a class of biologic therapies that selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation. The company’s drug discovery programs target growth factors which are present in the microenvironments of significant diseases, including fibrosis, musculoskeletal diseases, immuno-oncology, and autoimmune diseases. Its lead products include SRK-015, a selective and local inhibitor of latent myostatin activation for the treatment of primary myopathies. The company was founded in 2012 and is based in Cambridge, Massachusetts.

SRRK Latest News Stream

Event/Time News Detail
Loading, please wait...

SRRK Latest Social Stream

Loading social stream, please wait...

View Full SRRK Social Stream

Latest SRRK News From Around the Web

Below are the latest news stories about Scholar Rock Holding Corp that investors may wish to consider to help them evaluate SRRK as an investment opportunity.

Scholar Rock to Present at Cowen’s 42nd Annual Health Care Conference

CAMBRIDGE, Mass., February 25, 2022--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in an Orphan Neuro and Neuromuscular panel discussion at Cowen’s 42nd Annual Health Care Conference on Monday, March 7, 2022 at 9:10 a.m. ET.

Yahoo | February 25, 2022

The past year for Scholar Rock Holding (NASDAQ:SRRK) investors has not been profitable

As every investor would know, you don't hit a homerun every time you swing. But serious investors should think long and...

Yahoo | February 8, 2022

Scholar Rock to Present Biomarker Strategy for SRK-181 at the TGFβ for Immuno-Oncology Drug Development Summit

CAMBRIDGE, Mass., January 25, 2022--Scholar Rock today announced a presentation at the 2nd Annual TGFβ for Immuno-Oncology Drug Development Summit (January 25-27, 2022).

Yahoo | January 25, 2022

Scholar Rock (SRRK) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

No summary available.

Seeking Alpha | January 12, 2022

Scholar Rock Provides Corporate Update and Highlights Priorities for 2022

CAMBRIDGE, Mass., January 10, 2022--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today provided recent corporate updates and highlighted upcoming priorities for its pipeline programs in 2022.

Yahoo | January 10, 2022

Read More 'SRRK' Stories Here

SRRK Price Returns

1-mo -43.13%
3-mo -68.87%
6-mo N/A
1-year -81.13%
3-year -74.01%
5-year N/A
YTD -79.67%
2021 -48.82%
2020 268.21%
2019 -42.62%
2018 N/A
2017 N/A

Continue Researching SRRK

Here are a few links from around the web to help you further your research on Scholar Rock Holding Corp's stock as an investment opportunity:

Scholar Rock Holding Corp (SRRK) Stock Price | Nasdaq
Scholar Rock Holding Corp (SRRK) Stock Quote, History and News - Yahoo Finance
Scholar Rock Holding Corp (SRRK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7659 seconds.